Enhanced T Cell Migration to Sites of Microscopic CNS Disease: Complementary Treatments Evaluated by 2- and 3-D Image Analysis

Novel therapies are being developed to attack tumour or other abnormal cells within the brain. A general problem is the need for delivery to sites of microscopic disease. Leukocytes offer an attractive solution; they are able to both move through tissue and recognize abnormal targets. Leukocytes may...

Full description

Saved in:
Bibliographic Details
Published inBrain pathology (Zurich, Switzerland) Vol. 4; no. 2; pp. 125 - 134
Main Authors Lampson, Lois A., Chen, Anthony, Vortmeyer, Alexander O., Sloan, Andrew E., Ghogawala, Zoher, Kim, Lorence
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.04.1994
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Novel therapies are being developed to attack tumour or other abnormal cells within the brain. A general problem is the need for delivery to sites of microscopic disease. Leukocytes offer an attractive solution; they are able to both move through tissue and recognize abnormal targets. Leukocytes may act as effectors, or as vehicles for drugs, retroviral vectors or other agents. Here, we illustrate complementary ways of enhancing leukocyte migration to sites of microscopic central nervous system (CNS) disease. Enhanced T cell migration to sites of disseminated tumour is used as the example. Computer‐assisted image analysis is used to evaluate migration patterns in 2 and 3 dimensions. Shared regulatory features in the migration of tumour and responding cells, and the opportunities and questions they imply, are discussed.
Bibliography:ArticleID:BPA125
ark:/67375/WNG-5X7CPQMW-L
istex:0AB496123784BCD95B15FB65541CB19CB4EA2D07
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1015-6305
1750-3639
DOI:10.1111/j.1750-3639.1994.tb00823.x